ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0257

High Density Lipoprotein Bound miR-1246 Is Enriched in Patients with Rheumatoid Arthritis and Is Proinflammatory

Qiong Wu, Quanhu Sheng, Danielle Michell, Kasey Vickers and Michelle Ormseth, Vanderbilt University Medical Center, Nashville, TN

Meeting: ACR Convergence 2022

Keywords: Cardiovascular, Epigenetics, Inflammation, Micro-RNA, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: RA – Diagnosis, Manifestations, and Outcomes Poster I

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: High density lipoprotein (HDL) is known for its anti-atherogenic cholesterol efflux and antioxidant functions. HDL has additional relevance to rheumatoid arthritis (RA) because of its high concentration within the joint and its direct interaction with cells of the immune system and vasculature. Some studies have reported that patients with RA have altered HDL function. A function of HDL which has been unstudied in RA is its ability to transport microRNAs (miRNAs) between cells to alter gene expression and thus cellular function. The purpose of this study was to determine if miRNAs in HDL are altered in RA and if these HDL-miRNAs alter inflammation.

Methods: HDL was purified from 30 patients with RA and 30 control subjects by density gradient centrifugation and fast protein liquid chromatography. Total RNA was extracted from the purified HDL and matched plasma from each patient. Small RNA (sRNA) libraries were constructed and next generation sequencing (NGS) was performed. The TIGER pipeline was used to quantify miRNAs. miRNAs were compared between RA and control subjects by DESeq2 using 5% false discovery rate and multiple comparison adjustment by Benjamini-Hochberg method. Significantly altered miRNAs and miRNAs of interest were validated by qPCR. Putative function of miRNAs of interest was assessed by transfecting miRNA mimics, scramble control or no RNA controls into PMA-treated THP-1 cells (human monocyte-derived macrophages) stimulated with/without LPS and performing RNAseq. The function of miRNA targets was assessed by siRNA knockdown. Luciferase assay was performed to confirm targets.

Results: Patient demographics are presented in Table 1. Based on sRNA NGS and qPCR validation, miR-1246 was the most abundant miRNA and enriched in RA HDL. miR-1246 was more concentrated in HDL versus plasma (NGS base mean = 5781 in HDL versus NGS base mean 212 in plasma), suggesting HDL is the main carrier of miR-1246 in plasma. Further, miR-1246 was 3-fold enriched based on NGS and 1.9-fold enriched based on qPCR in RA versus control HDL (Figure 1a). Transfection of miR-1246 increased IL-6 expression 8-fold (Figure 1b). Based on mRNA NGS and qPCR validation, expression of DUSP3 was reduced significantly in miR-1246 transfected group compared to control group (Figure 2a). DUSP3 siRNA knockdown enhances LPS-induced IL-6 expression (Figure 2b). Luciferase assay indicated DUSP3 is a direct target of miR-1246 (Figure 2c).

Conclusion: HDL-bound miR-1246 is increased in RA versus control subjects. miR-1246 enhances LPS-induced IL-6 expression in human monocyte derived macrophages, likely through direct targeting of DUSP3. Further work will be dedicated to examining HDL delivery of miR-1246 based on disease state and the effect of miR-1246 on the anti/pro-inflammatory function of HDL in RA.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: Q. Wu, None; Q. Sheng, None; D. Michell, None; K. Vickers, None; M. Ormseth, None.

To cite this abstract in AMA style:

Wu Q, Sheng Q, Michell D, Vickers K, Ormseth M. High Density Lipoprotein Bound miR-1246 Is Enriched in Patients with Rheumatoid Arthritis and Is Proinflammatory [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/high-density-lipoprotein-bound-mir-1246-is-enriched-in-patients-with-rheumatoid-arthritis-and-is-proinflammatory/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-density-lipoprotein-bound-mir-1246-is-enriched-in-patients-with-rheumatoid-arthritis-and-is-proinflammatory/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology